ID
11995
Beschrijving
Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01649050
Link
https://clinicaltrials.gov/show/NCT01649050
Trefwoorden
Versies (1)
- 30-08-15 30-08-15 -
Geüploaded op
30 augustus 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
Patients with symptoms of spasticity not due to MS.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0026838
Beschrijving
Patients taking three or more different anti-spasticity medications.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0026838
Beschrijving
Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0235874
- UMLS CUI [2]
- C0026769
Beschrijving
Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0015980
Beschrijving
Use of baclofen pump at any time.
Datatype
boolean
Alias
- UMLS CUI [1]
- C3836732
Beschrijving
Wheelchair or bed-bound patients.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0043143
Similar models
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
- StudyEvent: Eligibility
C0332307 (UMLS CUI [2])
C0026769 (UMLS CUI [2])
C0026769 (UMLS CUI [2])
C0026838 (UMLS CUI [2])
C0026769 (UMLS CUI [2])